老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Renaissance International IPO ETF
22.30
+0.2027
0.92%
盤後：
22.27
-0.0327
-0.15%
16:10 EDT
成交量：
468
成交額：
1.04萬
市值：
1,114.89萬
市盈率：
- -
高：
22.30
開：
22.21
低：
22.21
收：
22.10
52周最高：
26.25
52周最低：
15.65
股本：
50.00萬
流通股本：
50.00萬
量比：
0.27
換手率：
0.09%
股息：
0.14
股息率：
0.64%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
華泰金融控股(香港)刊發補充上市文件 擬發行5系列單一股份權證擬於9月16日上市
财闻
·
09/14
限售股解禁，摩爾線程、沐曦股份股價先後創歷史新低
潮新闻
·
09/14
日本 NAND 巨頭鎧俠考慮在美國上市，擬融資 100 億美元
链捕手
·
09/14
晶合集成2023年股權激勵預留部分首批歸屬14.16萬股 9月18日上市流通
财闻
·
09/14
報道：鎧俠考慮赴美發行ADR募資至少100億美元，或於明年上市
华尔街见闻
·
09/14
市場消息：鎧俠正考慮在美國上市籌集100億美元。
智通财经
·
09/14
恒瑞醫藥(01276.HK)：SHR-2004注射液的藥品上市許可申請獲國家藥監局受理
智通财经
·
09/14
燧原科技上市首日大漲 國產算力「四小龍」迎盈利大考
经济导报
·
09/14
摩爾線程跌3.31% 二季度末永贏基金為最大流通股東
中金财经
·
09/14
發布會提及213次，五大上市險企AI應用從「百億投入」邁向「算賬」階段？|半年報關鍵詞AI
市场资讯
·
09/14
元道通信4年造假被罰2.39億，還有3億涉訴債務誰來兜底？
市场资讯
·
09/14
恒瑞創新藥凝血因子XI單抗SHR-2004注射液用於擇期膝關節置換手術後成年患者靜脈血栓預防的上市申請獲受理
恒瑞医药
·
09/14
非息收入僅增0.23%，9家上市股份行忙了個「寂寞」？代理業務冰火兩重天，財富回暖為何沒能帶動中收？
市场资讯
·
09/14
恒瑞醫藥：SHR-2004注射液上市許可申請獲受理
每日经济新闻
·
09/14
恒瑞醫藥：SHR-2004注射液上市許可申請獲受理
智通财经
·
09/14
海柔創新再度向港交所主板遞表 聯席保薦為高盛與中信證券
观点地产网
·
09/14
華海藥業：阿哌沙班片獲得德國上市許可
智通财经
·
09/14
豐收開新局 實幹促振興 | 海門無花果上市銷售
江川发布
·
09/14
【美股盤前】AI發展放緩呼聲引發市場擔憂，芯片與存儲股集體下跌，英偉達下跌2.5%，英特爾、AMD跌超5%；高管稱波士頓動力IPO條件尚不成熟；沙特管道遇襲停運，布油升逾3%
每日经济新闻
·
09/14
上周無新增IPO受理企業
智通财经
·
09/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/IPOS/news?page=20"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IPOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","market":"US","secType":"STK","nameCN":"Renaissance International IPO ETF","latestPrice":22.2977,"timestamp":1789761600000,"preClose":22.095,"halted":0,"volume":468,"hourTrading":{"tag":"盘后","latestPrice":22.265,"preClose":22.2977,"latestTime":"16:10 EDT","volume":6,"amount":133.7862,"timestamp":1789762204013,"change":-0.0327,"changeRate":-0.001467,"amplitude":0},"delay":0,"changeRate":0.009174021271780951,"floatShares":500001,"shares":500001,"eps":0,"marketStatus":"休市中","change":0.2027,"latestTime":"09-18 16:00:00 EDT","open":22.205,"high":22.2977,"low":22.205,"amount":10412,"amplitude":0.004196,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":22.095,"sharesOutstanding":400001,"nav":22.413406,"aum":11206725.19,"dividendRate":0.00644,"bidAskSpread":0.00529,"postHourTrading":{"tag":"盘后","latestPrice":22.265,"preClose":22.2977,"latestTime":"16:10 EDT","volume":6,"amount":133.7862,"timestamp":1789762204013,"change":-0.0327,"changeRate":-0.001467,"amplitude":0},"volumeRatio":0.2664540955104705,"impliedVol":0.8847,"impliedVolPercentile":0.9761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","floatShares":500001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2664540955104705,"shares":500001,"dividePrice":0.1436,"high":22.2977,"amplitude":0.004196,"preClose":22.095,"low":22.205,"week52Low":15.65,"pbRate":"--","week52High":26.25,"institutionHeld":0,"latestPrice":22.2977,"eps":0,"divideRate":0.00644,"volume":468,"delay":0,"ttmEps":0,"open":22.205,"prevYearClose":16.8936,"prevWeekClose":22.665,"prevMonthClose":23.3188,"prevQuarterClose":25.635,"fiveDayClose":22.665,"twentyDayClose":23.2622,"sixtyDayClose":24.8672},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPOS\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"IPOS","amount":0.072205,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-18"},{"date":"2026-06-12","symbol":"IPOS","amount":0.054103,"announcedDate":"2026-06-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-12","defaultRemindTime":1781271000000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-12","currency":"USD","dateTimestamp":1781236800000,"payDate":"2026-06-22"},{"date":"2025-12-12","symbol":"IPOS","amount":0.017941,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-19"},{"date":"2025-09-12","symbol":"IPOS","amount":0.007352,"announcedDate":"2025-09-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-12","defaultRemindTime":1757683800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-12","currency":"USD","dateTimestamp":1757649600000,"payDate":"2025-09-19"},{"date":"2025-06-13","symbol":"IPOS","amount":0.13555,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPOS\",market:\"US\",,,undefined,":[{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.15245,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-22","value":0.05857,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-23","value":0.00775,"currency":"USD"},{"executeDate":"2018-06-15","recordDate":"2018-06-18","paymentDate":"2018-06-22","value":0.2024,"currency":"USD"},{"executeDate":"2018-12-14","recordDate":"2018-12-17","paymentDate":"2018-12-21","value":0.80265,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPOS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPOS\",pageSize:20,pageCount:20,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667066870","title":"華泰金融控股(香港)刊發補充上市文件 擬發行5系列單一股份權證擬於9月16日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066870","media":"财闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066870?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:06","pubTimestamp":1789383960,"startTime":"0","endTime":"0","summary":"9月14日，华泰金融控股(香港)有限公司刊发补充上市文件，拟发行5系列欧式现金结算单一股份权证，相关股份涵盖江西赣锋锂业、中国平安、中国人寿、北京智谱华章及宁德时代的H股。权证推出日为2026年9月11日，发行日为2026年9月15日，拟上市日为2026年9月16日，到期日介乎2027年4月1日至2027年7月30日。发行人董事会于2021年5月17日授权发行权证，权证须待取得联交所上市批准后方可发行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuu7289955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","159940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663613","title":"限售股解禁，摩爾線程、沐曦股份股價先後創歷史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663613","media":"潮新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663613?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:04","pubTimestamp":1789383840,"startTime":"0","endTime":"0","summary":"而去年12月5日上市的“国产GPU第一股”摩尔线程和紧接着上市的沐曦股份，随着限售股解禁和解禁日期临近，股价9月11日和今天盘中先后创历史新低，其中摩尔线程今天收盘跌3.11%，沐曦股份收盘跌5.71%。沐曦股份限售股解禁情况与1033元/股的上市以来最高价相比，沐曦股份的股价已下跌了55.36%，同样已经腰斩以上。而股价暴涨后总市值虚高，一旦限售股大批量解禁，股价大幅下挫，上市后买入的投资者很容易高位“站岗”。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuy4557382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667465079","title":"日本 NAND 巨頭鎧俠考慮在美國上市，擬融資 100 億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667465079","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667465079?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:51","pubTimestamp":1789383114,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，市场消息：日本 NAND 巨头铠侠控股正考虑在美国上市筹集 100 亿美元。该公司正在与美国银行、高盛和摩根大通进行洽谈，以寻求在美国获得更多流动性。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2289666","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MUZ","MUG","DRMP","MUYY","DRAM","MUD","MULL","RAM","BK4588","IPOS","MUU","MIC","DRAL","RAMZ","DRMY","DISK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668073","title":"晶合集成2023年股權激勵預留部分首批歸屬14.16萬股 9月18日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668073","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668073?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:51","pubTimestamp":1789383060,"startTime":"0","endTime":"0","summary":"9月14日，晶合集成完成2023年限制性股票激励计划预留授予部分第一个归属期的股份登记工作，本次归属股份141,613股将于2026年9月18日上市流通。归属股票来源为公司定向发行的人民币A股普通股，激励对象均不属于公司董事和高级管理人员。容诚会计师事务所于2026年9月2日出具验资报告，截至2026年8月26日，公司收到5名激励对象缴纳的141,613股股权认购款合计人民币1,411,881.61元，其中计入股本141,613.00元，计入资本公积1,270,268.61元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuw4063613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","BK1163","02249","BK0214","688249"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667366838","title":"報道：鎧俠考慮赴美發行ADR募資至少100億美元，或於明年上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667366838","media":"华尔街见闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667366838?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:48","pubTimestamp":1789382888,"startTime":"0","endTime":"0","summary":"铠侠正考虑赴美发行ADR，募资至少100亿美元，最快明年上市，并已与美国银行、高盛、摩根大通等展开磋商。受AI存储需求带动，铠侠日股年内涨超410%，市值升至约1800亿美元，但近期业绩不及预期，赴美融资仍需面对估值与市场波动的考验。","market":"us","thumbnail":"https://static.tigerbbs.com/266ab84342c6ca65b538d0b42bc1dc4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/266ab84342c6ca65b538d0b42bc1dc4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3781715","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIVL","IPOS","KXIAY","SAPH","DINT","ARMH","KXHCF","AADR","CVY","APIE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650657","title":"市場消息：鎧俠正考慮在美國上市籌集100億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650657","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:46","pubTimestamp":1789382815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657078","title":"恒瑞醫藥(01276.HK)：SHR-2004注射液的藥品上市許可申請獲國家藥監局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:36","pubTimestamp":1789382173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765668","title":"燧原科技上市首日大漲 國產算力「四小龍」迎盈利大考","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765668","media":"经济导报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765668?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:17","pubTimestamp":1789381020,"startTime":"0","endTime":"0","summary":"随着这声锣响,摩尔线程、沐曦股份、壁仞科技、燧原科技4家国产算力芯片企业齐聚资本市场。从2025年12月摩尔线程率先上市算起,这场“会师”历时9个月。不过,燧原科技的首日表现并不算最亮眼。首日涨幅的逐级回落,本身就是一条清晰的信号——国产算力芯片在二级市场的“稀缺性溢价”,正在被稀释。截至目前,“四小龙”尚未盈利,如何撑起国产算力的市值?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuw4054012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657661","title":"摩爾線程跌3.31% 二季度末永贏基金為最大流通股東","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657661","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657661?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:08","pubTimestamp":1789380493,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 摩尔线程 今日收报346.02元，跌幅3.31%。 截至2026年6月30日，上海浦东发展银行股份有限公司－永赢数字经济智选混合型发起式证券投资基金持有1250276股，占流通股比例为4.136%，为摩尔线程第一大流通股股东。 摩尔线程于2026年8月10日披露了关于筹划发行H股股票并在香港联合交易所有限公司主板上市的提示性公告。本次发行并上市能否通过审议、备案和审核程序并最终实施具有重大不确定性。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914870190.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914870190.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32369287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688795","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667577326","title":"發布會提及213次，五大上市險企AI應用從「百億投入」邁向「算賬」階段？|半年報關鍵詞AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2667577326","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667577326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:08","pubTimestamp":1789380480,"startTime":"0","endTime":"0","summary":"2026年中期业绩发布会，“AI”“token”等人工智能用词，成为A股五大上市险企第一热词。213次热词的支撑，来自“十五五”开局之年的战略落子。不过，只有中国平安在报告中披露了Token消耗量，在五大上市险企中仅此一家。投入阶段已过半，进入“算账”阶段。业绩发布会上，中国人寿总裁助理、首席网络安全官张新宇表示，基于大模型的意外险、重疾险责任辅助判定投入使用，理赔时效缩短至0.36天；面向销售人员的“AI私教”培训体系已经上线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/2026-09-14/doc-iniruxus9363834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","VTHR","AIPO","AGIX","AIQ","CHAT","IPOS","BK4585","QTOC","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667465790","title":"元道通信4年造假被罰2.39億，還有3億涉訴債務誰來兜底？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667465790","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667465790?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:05","pubTimestamp":1789380300,"startTime":"0","endTime":"0","summary":"如今，因涉欺诈发行及信息披露违法行为，元道通信被罚款2.39亿元，同时退市进入倒计时。退市主要问题归于其4年的财务造假。2025年7月11日，元道通信被证监会立案调查，2026年5月8日公司收到《行政处罚事先告知书》。潘建忠、乔军文被认定为不适当人选，12个月内不得担任保荐相关职务。元道通信上市三年、案发时市值仍有二十多亿元，一旦索赔诉讼成势，收了8418万元的国新证券，面对的可能是数倍于此的赔付责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-14/doc-iniruxuy4522694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0244354667.USD","LU0370786039.SGD","LU1831875114.USD","LU1366334578.USD","LU1008478684.HKD","IE00BVYPNQ40.USD","IE0008369823.USD","LU1251922891.USD","LU0228367735.SGD","LU1328277881.USD","03143","LU1960683339.HKD","LU0327786744.USD","LU1242518857.USD","IE0031814852.USD","IE00BVYPNP33.GBP","LU0502904849.HKD","LU1993786604.SGD","LU1719994722.HKD","LU1807302812.USD","IPOS","LU0588546209.SGD","LU1188198961.HKD","LU0307460666.USD","LU0561508036.HKD","LU0979878070.USD","LU0315179316.USD","LU2476274308.USD","LU0868486357.SGD","LU0348805143.USD","LU0117841782.USD","LU1152091754.HKD","LU1226287529.USD","IE00BZ08YT58.USD","LU0417516902.SGD","LU0516422366.SGD","IE00B29SXG58.USD","IE00BYV24P56.USD","LU2294711473.HKD","LU1813983027.USD","03968","LU0348788117.USD","LU0456827905.SGD","LU0348814723.USD","LU1282649141.HKD","LU1366334651.USD","LU0880133367.SGD","HK0000352291.HKD","LU0314109678.HKD","LU0431992006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657738","title":"恒瑞創新藥凝血因子XI單抗SHR-2004注射液用於擇期膝關節置換手術後成年患者靜脈血栓預防的上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657738","media":"恒瑞医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657738?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:59","pubTimestamp":1789379940,"startTime":"0","endTime":"0","summary":"近日，恒瑞医药子公司北京盛迪医药有限公司收到国家药监局下发的《受理通知书》，公司1类创新药、凝血因子XI单克隆抗体SHR-2004注射液的药品上市许可申请获受理，拟定适应症为：用于择期膝关节置换手术的成年患者，以预防静脉血栓形成。该研究旨在评价行择期TKA的患者使用SHR-2004注射液预防静脉血栓栓塞症的有效性和安全性。此外，SHR-2004用于卵巢癌术后VTE预防的Ⅱ期试验已完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuy4531842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1574","MEDX","159992","IPOS","06978","IBBQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965773","title":"非息收入僅增0.23%，9家上市股份行忙了個「寂寞」？代理業務冰火兩重天，財富回暖為何沒能帶動中收？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965773","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667965773?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:54","pubTimestamp":1789379640,"startTime":"0","endTime":"0","summary":"部分银行的财富管理相关收入恢复较快，譬如民生银行，该行上半年代理业务手续费增长64.92%；另外，招行代理基金手续费增长61.40%，平安银行代理及委托手续费增长27.6%。今年上半年，9家股份行中，6家非息收入正增长，3家负增长。因此，非息收入增长或下降，并不能简单等同于中收的同步变化。代理业务表现“冰火两重天”进一步拆分手续费收入，财富管理业务的变化更为明显。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/bank/gsdt/2026-09-14/doc-iniruxuu7251063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667265224","title":"恒瑞醫藥：SHR-2004注射液上市許可申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667265224","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667265224?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:49","pubTimestamp":1789379352,"startTime":"0","endTime":"0","summary":"9月14日，恒瑞医药公告称，公司子公司北京盛迪医药收到国家药监局下发的《受理通知书》，公司1类创新药、凝血因子XI单克隆抗体SHR-2004注射液的药品上市许可申请获受理。该药品拟定适应症为用于择期膝关节置换手术的成年患者，以预防静脉血栓形成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873526173.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873526173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","LU0405327494.USD","LU1328615791.USD","LU1997245094.SGD","LU0359201885.HKD","LU1655091616.SGD","BK0028","BK0060","LU1023057109.AUD","LU2580892789.USD","LU1997244956.HKD","LU2097828557.USD","LU1969619763.USD","LU2543165471.USD","BK0196","LU2289578879.USD","LU2580892862.HKD","LU1064130708.USD","LU2148510915.USD","01276","BK0239","LU1146622755.USD","LU0405327148.USD","LU2097828631.EUR","LU2495084118.USD","LU2097828714.EUR","LU2488822045.USD","BK1191","LU0359201612.USD","LU1781817850.SGD","LU1064131003.USD","BK0188","LU1255011170.USD","600276","LU1580142542.USD","LU1820825898.SGD","LU1997245177.USD","LU0359202008.SGD","BK0183","IPOS","BK0012","LU2097828805.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652502","title":"恒瑞醫藥：SHR-2004注射液上市許可申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667652502?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:46","pubTimestamp":1789379185,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650823","title":"海柔創新再度向港交所主板遞表 聯席保薦為高盛與中信證券","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650823","media":"观点地产网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650823?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:43","pubTimestamp":1789378980,"startTime":"0","endTime":"0","summary":"观点网讯：9月13日，深圳市海柔创新智慧科技集团股份有限公司向港交所主板递交上市申请，联席保荐人为高盛、中信证券。招股书显示，海柔创新是一家仓储自动化领域的企业，专注于拣选自动化解决方案，拣选是仓库中最为劳动密集及耗时的活动。此次为该公司再度递表。海柔创新曾于今年2月13日向港交所递交上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/estate/integration/2026-09-14/doc-iniruxuw3993623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06030","LU0345770993.USD","IPOS","HEXmain","LU0106831901.USD","LU2471134796.USD","BK0028","LU0742534661.SGD","LU0942090050.USD","LU1997245177.USD","IE00B19Z3581.USD","LU0048573561.USD","LU2148510915.USD","LU0061475181.USD","BK1521","LU1580142542.USD","600030","LU1868836591.USD","BK1516","LU1720050803.USD","LU2237443382.USD","IE00B19Z3B42.SGD","BK4552","LU2237443978.SGD","LU1064131003.USD","BK4585","LU1255011170.USD","LU1868836914.USD","IE0002270589.USD","BK0183","LU2237443549.SGD","BK4127","LU0868494708.USD","LU1655091616.SGD","BK1147","LU1894683264.USD","LU0345770308.USD","BK4550","GSX","LU2471134879.HKD","LU1781817850.SGD","LU1668664300.SGD","IE0004091025.USD","LU2237438978.USD","LU1997244956.HKD","LU1146622755.USD","LU0251142724.SGD","LU1328615791.USD","BK0012","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654723","title":"華海藥業：阿哌沙班片獲得德國上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654723?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:39","pubTimestamp":1789378774,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765221","title":"豐收開新局 實幹促振興 | 海門無花果上市銷售","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765221","media":"江川发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765221?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:36","pubTimestamp":1789378560,"startTime":"0","endTime":"0","summary":"在成熟上市周期方面，基地无花果每年8月底开始陆续成熟，进入初采阶段，可供少量采摘与销售；每年9月15日后果实进入集中成熟期，大批量鲜果可上市供应，能够精准对接秋季鲜果市场需求，抢占市场销售窗口期。产量方面，基地无花果产量呈逐年稳步递增的丰产态势，种植收益稳定可期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-14/doc-iniruxus9352664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667523116","title":"【美股盤前】AI發展放緩呼聲引發市場擔憂，芯片與存儲股集體下跌，英偉達下跌2.5%，英特爾、AMD跌超5%；高管稱波士頓動力IPO條件尚不成熟；沙特管道遇襲停運，布油升逾3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667523116","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667523116?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:32","pubTimestamp":1789378366,"startTime":"0","endTime":"0","summary":"①【三大期指齐跌】截至发稿，道指期货跌0.18%，标普500指数期货跌0.69%，纳指期货跌1.72%。②【AI发展放缓呼声引发市场担忧，芯片与存储股集体下跌】9月12日，AnthropicCEO达里奥·阿莫代伊（DarioAmodei）发表文章，呼吁业界放缓AI模型的开发节奏，引发投资者广泛关注。阿莫代伊在文章中提出了一项“放缓前沿竞争”的计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873505440.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873505440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FDTX","REDS","SOXQ","XSD","SMH","SNPE","159813","AIS","CHPY","LINT","UCO","ARTY","INTC","LFGY","SOXX","USD","QTOC","NVIW.SI","AIPO","KCE","AGIX","LEGR","CLSE","AMD","SOXL","CHPS","SMHX","VTHR","SCO","IPOS","AGOX","CHAT","TTXU","DBO","CNEQ","PSI","SSG","TEKX","NVDA","SOXS","EFIV","ESLG","SOXY","TTEQ","FRHC","USO","FTXL","THMR","CNAV","GFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693654","title":"上周無新增IPO受理企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693654?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:25","pubTimestamp":1789377948,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FRHC","REDS","BK4127","IPOS","KCE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":51,"pageCount":20,"totalSize":1007,"code":"91000000","status":"200"}]}}